The present invention is directed to a stable formulation of a combination of ketorolac (non steroidal anti inflammatory drug) with olopatadine (anti- histaminic drug) intended for ophthalmic use. This pharmaceutical composition is used for treatment of ophthalmic diseases and conditions particularly seasonal ocular surface allergy.